236
Participants
Start Date
April 20, 2019
Primary Completion Date
November 11, 2020
Study Completion Date
June 10, 2021
Percutaneous left atrial appendage closure-LAMax
Interventional device, LAMax left atrial appendage closure system
Percutaneous left atrial appendage closure-Watchman
Interventional device, Watchman® LAA Closure Device
The Third Medical Center, Chinese People's Liberation Army General Hospital, Beijing
The First Hospital of Jilin University, Changchun
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai
General Hospital of Tianjin Medical University, Tianjin
The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou
The First Municipal hospital of Ningbo, Ningbo
The Second Affiliated Hospital of Nanchang University, Nanchang
The First Affiliated Hospital of Nanchang University, Nanchang
Ganzhou Municipal Hospital, Ganzhou
The Second Affiliated Hospital of Chongqing Medical University, Chongqing
The First Hospital of Lanzhou University, Lanzhou
The Second Hospital of Hebei Medical University, Shijiazhuang
The Third Medical Center, Chinese People's Liberation Army General Hospital
UNKNOWN
The Second Affiliated Hospital of Chongqing Medical University
OTHER
Ganzhou Municipal Hospital
UNKNOWN
First Affiliated Hospital of Guangxi Medical University
OTHER
The Second Hospital of Hebei Medical University
OTHER
The First Hospital of Jilin University
OTHER
LanZhou University
OTHER
Second Affiliated Hospital of Nanchang University
OTHER
The First Affiliated Hospital of Nanchang University
OTHER
The First Municipal hospital of Ningbo
UNKNOWN
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
OTHER
Tianjin Medical University General Hospital
OTHER
ShenZhen KYD Biomedical Technology Co., Ltd.
INDUSTRY
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER